JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2009, 58(2):67-70

Production of isoflavonoids in the Trifolium pratense L. suspension culture

M. Kašparová*, T. Siatka, J. Dušek
Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Department of Pharmacognosy, Czech Republic

The plant Trifolium pratense L. contains a wide spectrum of constituents. Regarding the utilization of the red clover plant for therapeutic purposes, the most interesting substances are isoflavonoids. They are listed in the same class with the most important phytoestrogens. The explant cultures are a promising source of secondary metabolites, thus also of isoflavonoids. However, their production, when compared with intact plants, is usually lower and this is the reason why we are looking for different methods and approaches to increase the production. The objective of this study was to observe the influence of three elicitors - the salicylic acid, cadmium chloride, and mercury chloride - on the production of isoflavonoids by the Trifolium pratense L. suspension culture (Sprint variety). The best elicitation effect was observed with mercury chloride. The maximum increase in production was observed after a 6-hour application of the 1 μmol concentration when, after the comparison with the control sample, the production of daidzein was increased by 1300%, that of genistin by 375%, and that of genistein by 300%.

Keywords: Trifolium pratense L. suspension culture; production of isoflavonoids; biotic and abiotic elicitation

Received: March 13, 2009; Accepted: April 6, 2009; Published: February 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kašparová M, Siatka T, Dušek J. Production of isoflavonoids in the Trifolium pratense L. suspension culture. Čes. slov. farm. 2009;58(2):67-70.
Download citation

References

  1. Dixon, R. A.: Ann. Rev. Plant Biol., 2004; 55, 225. Go to original source... Go to PubMed...
  2. Ososki, A. L., Kennelly, E. J.: Phytoter. Res., 2003; 17, 845. Go to original source... Go to PubMed...
  3. Tham, D. M. et al.: J. Clin. Endocrinol. Metab., 1998; 83, 2223.
  4. Radman, R. et al.: Biotechnol. Appl. Biochem., 2003; 37, 91. Go to original source... Go to PubMed...
  5. Wu, J., Lin, L.: Appl. Microbiol. Biotechnol., 2002; 59, 51.
  6. Gamborg, O. L., Miller, R. A., Ojima, K.: Exp. Cell Res., 1968; 50, 151. Go to original source... Go to PubMed...
  7. Kašparová, M., Siatka, T., Spilková, J., Dušek, J.: Čes. slov. Farm., 2006; 55, 44.
  8. Pita-Alvarez, S. I., Spollansky, T. C., Giulietti, A. M.: Enzyme Microb. Technol., 2000; 26, 252. Go to original source... Go to PubMed...
  9. Ignatov, A. et al.: Phytochemistry, 1996; 43, 1141. Go to original source... Go to PubMed...
  10. Kašparová, M., Siatka, T., Dušek, J.: Čes. slov. Farm., 2007; 56, 225.
  11. Tebayashi, S., Ishihara, A., Iwamura, H.: J. Exp. Bot., 2001; 52, 681. Go to original source... Go to PubMed...
  12. Kartosentono, S. et al.: Biotechnol. Lett., 2002; 24, 687. Go to original source...
  13. Tůmová, L., Blažková, R.: Čes. slov. Farm., 2002; 51, 44.
  14. Kašparová, M., Siatka, T., Dušek, J.: Čes. slov. Farm., 2008; 57, 107.
  15. De Rijke, E. et al.: Anal. Chim. Acta, 2002; 468, 3. Go to original source...
  16. Thomma, B. P. H., Eggermont, K.: Proc. Natl. Acad. Sci. USA, 1998; 95, 15107. Go to original source... Go to PubMed...
  17. Zhao, J., Davis, L. C., Verpoorte, R.: Biotechnol. Advanc., 2005; 23, 283. Go to original source... Go to PubMed...
  18. Mithöfer, A., Schulze, B., Boland, W.: Febs Lett., 2004; 566, 1. Go to original source... Go to PubMed...
  19. Israr, M., Sahi, S.: Plant Physiol. Biochem, 2006; 44, 590. Go to original source... Go to PubMed...
  20. Israr, M., Sahi, S., Datta, R., Sarkar, D.: Chemosphere, 2006; 65, 591. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.